Charles Hu Email & Phone Number

Charles Hu Work

• CEO of Ryoden Medical Holdings @ Ryoden Development Limited (January 2019 - Present)
• Healthcare and Biotech Investments @ Ryoden Development Limited (October 2017 - January 2019)
• Industrial Advisor @ Hong Kong Centre for Cerebro-cardiovascular Health Engineering (May 2026 - Present)
• Co-Founder @ Incando Therapeutics (April 2019 - Present)
• Chief Executive Officer @ Incando Therapeutics (January 2025 - Present)
• Founding Partner @ Cere Ventures Ltd (November 2021 - Present)
• Chairman of BME Departmental Advisory Committee @ City University of Hong Kong (September 2024 - Present)
• Adjunct Professor of Biomedical Sciences @ City University of Hong Kong (May 2024 - Present)
• HK Tech 300 Selection Panelist and Mentor @ City University of Hong Kong (October 2022 - Present)
• Industrial Advisor of Biomedical Engineering @ City University of Hong Kong (July 2022 - Present)
• Visiting Assistant Professor of Biomedical Sciences @ City University of Hong Kong (May 2023 - May 2024)
• Board Member @ Asian Fund for Cancer Research (November 2024 - Present)
• Advisory Council Member @ Asian Fund for Cancer Research (September 2023 - November 2024)
• Vice President @ HKBIO (July 2019 - Present)
• Service Promotion Programme Committee Member @ Hong Kong Trade Development Council (October 2025 - Present)
• Asia Summit on Global Health (ASGH) Steering Committee Member @ Hong Kong Trade Development Council (July 2024 - Present)
• Committee Member @ Hong Kong Professionals And Senior Executives Association (August 2023 - Present)
• ITF Research Projects Assessment Panel Member @ Innovation and Technology Commission (November 2024 - Present)
• Guest Mentor @ Deep-Tech Lab (March 2026 - Present)
• Industry Advisor @ EQT Partners/EQT AB (January 2025 - Present)
• Advisor @ Gobi Partners (June 2025 - Present)
  View Department
• Advisor @ Hai Kang Life Corporation Limited (October 2019 - Present)
• Advisor @ Grays Ferry Capital (March 2019 - Present)
• Medical Advisor in Cardiovascular, Renal and Metabolism @ AstraZeneca (October 2019 - February 2021)
• Intellectual Property Management @ City University of Hong Kong (March 2019 - October 2019)
• Ph.D. Candidate, Translational Tissue Engineering @ The Johns Hopkins University (August 2011 - May 2017)
• Research Assistant, Chemical and Biomolecular Engineering @ The BASE (HKUST) (May 2011 - August 2011)
  View Department
• Research Technologist, Biomedical Engineering @ The Johns Hopkins University School of Medicine (August 2009 - April 2011)
  View Department
• Associate Science Researcher @ Tronex International, Inc. (May 2009 - August 2009)
• Research Assistant @ The Chinese University of Hong Kong (February 2009 - April 2009)
• Undergraduate Researcher @ University of California, Berkeley (January 2008 - December 2008)
• Private Banking and Wealth Management @ Citi (June 2008 - August 2008)
  View Department